Mattion N - Search Results

1

Updating of the correlation between lpELISA titers and protection from virus challenge for the assessment of the potency of polyvalent aphtovirus vaccines in Argentina.

Maradei E, La Torre J, Robiolo B, Esteves J, Seki C, Pedemonte A, Iglesias M, D'Aloia R, Mattion N. Maradei E, et al. Among authors: mattion n. Vaccine. 2008 Dec 2;26(51):6577-86. doi: 10.1016/j.vaccine.2008.09.033. Vaccine. 2008. PMID: 18835312

2

Reintroduction of foot-and-mouth disease in Argentina: characterisation of the isolates and development of tools for the control and eradication of the disease.

Mattion N, König G, Seki C, Smitsaart E, Maradei E, Robiolo B, Duffy S, León E, Piccone M, Sadir A, Bottini R, Cosentino B, Falczuk A, Maresca R, Periolo O, Bellinzoni R, Espinoza A, Torre JL, Palma EL. Mattion N, et al. Vaccine. 2004 Oct 22;22(31-32):4149-62. doi: 10.1016/j.vaccine.2004.06.040. Vaccine. 2004. PMID: 15474705

3

Foot-and-mouth disease polyvalent oil vaccines inoculated repeteadly in cattle do not induce detectable antibodies to non-structural proteins when evaluated by various assays.

Espinoza AM, Maradei E, Mattion N, Cadenazzi G, Maddonni G, Robiolo B, La Torre J, Bellinzoni R, Smitsaart E. Espinoza AM, et al. Among authors: mattion n. Vaccine. 2004 Nov 15;23(1):69-77. doi: 10.1016/j.vaccine.2004.05.007. Vaccine. 2004. PMID: 15519709

4

Analysis of the immune response to FMDV structural and non-structural proteins in cattle in Argentina by the combined use of liquid phase and 3ABC-ELISA tests.

Robiolo B, Seki C, Fondevilla N, Grigera P, Scodeller E, Periolo O, La Torre J, Mattion N. Robiolo B, et al. Among authors: mattion n. Vaccine. 2006 Feb 13;24(7):997-1008. doi: 10.1016/j.vaccine.2005.08.071. Epub 2005 Sep 7. Vaccine. 2006. PMID: 16171905

5

Rapid methodology for antigenic profiling of FMDV field strains and for the control of identity, purity and viral integrity in commercial virus vaccines using monoclonal antibodies.

Seki C, Robiolo B, Periolo O, Iglesias M, D'Antuono A, Maradei E, Barros V, La Torre J, Mattion N. Seki C, et al. Among authors: mattion n. Vet Microbiol. 2009 Jan 13;133(3):239-51. doi: 10.1016/j.vetmic.2008.07.011. Epub 2008 Jul 26. Vet Microbiol. 2009. PMID: 18774662

6

Some guidelines for determining foot-and-mouth disease vaccine strain matching by serology.

Mattion N, Goris N, Willems T, Robiolo B, Maradei E, Beascoechea CP, Perez A, Smitsaart E, Fondevila N, Palma E, De Clercq K, La Torre J. Mattion N, et al. Vaccine. 2009 Jan 29;27(5):741-7. doi: 10.1016/j.vaccine.2008.11.026. Epub 2008 Nov 27. Vaccine. 2009. PMID: 19041355

7

Quantitative single serum-dilution liquid phase competitive blocking ELISA for the assessment of herd immunity and expected protection against foot-and-mouth disease virus in vaccinated cattle.

Robiolo B, La Torre J, Duffy S, Leon E, Seki C, Torres A, Mattion N. Robiolo B, et al. Among authors: mattion n. J Virol Methods. 2010 Jun;166(1-2):21-7. doi: 10.1016/j.jviromet.2010.02.011. Epub 2010 Feb 17. J Virol Methods. 2010. PMID: 20170683

8

Confidence in indirect assessment of foot-and-mouth disease vaccine potency and vaccine matching carried out by liquid phase ELISA and virus neutralization tests.

Robiolo B, La Torre J, Maradei E, Beascoechea CP, Perez A, Seki C, Smitsaart E, Fondevila N, Palma E, Goris N, De Clercq K, Mattion N. Robiolo B, et al. Among authors: mattion n. Vaccine. 2010 Aug 31;28(38):6235-41. doi: 10.1016/j.vaccine.2010.07.012. Epub 2010 Jul 17. Vaccine. 2010. PMID: 20643090

9

HSV-1 amplicon vectors that direct the in situ production of foot-and-mouth disease virus antigens in mammalian cells can be used for genetic immunization.

D'Antuono A, Laimbacher AS, La Torre J, Tribulatti V, Romanutti C, Zamorano P, Quattrocchi V, Schraner EM, Ackermann M, Fraefel C, Mattion N. D'Antuono A, et al. Among authors: mattion n. Vaccine. 2010 Oct 28;28(46):7363-72. doi: 10.1016/j.vaccine.2010.09.011. Epub 2010 Sep 17. Vaccine. 2010. PMID: 20851082

10

Characterization of foot-and-mouth disease virus from outbreaks in Ecuador during 2009-2010 and cross-protection studies with the vaccine strain in use in the region.

Maradei E, Perez Beascoechea C, Malirat V, Salgado G, Seki C, Pedemonte A, Bonastre P, D'Aloia R, La Torre JL, Mattion N, Rodríguez Toledo J, Bergmann IE. Maradei E, et al. Among authors: mattion n. Vaccine. 2011 Oct 26;29(46):8230-40. doi: 10.1016/j.vaccine.2011.08.120. Epub 2011 Sep 10. Vaccine. 2011. PMID: 21911020

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters